Sponsor pipeline

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh clinical trial pipeline

Get alerts when Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

  1. Notable

    Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS

    Primary completion pushed from Nov 30, 2025 to Dec 30, 2026

    Also in this update: Enrollment increased: 100 → 150 participants; Study completion pushed from Nov 30, 2025 to Feb 28, 2027

    Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshPhase 4 NCT05680805 Registry history of NCT05680805 on ClinicalTrials.gov (opens the registry)

Show 1 trial with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
1
Phase 3
3
Phase 4
2
Not charted: 10 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free